TREATMENT SEQUENCING PATTERNS AND COSTS OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

被引：4
|
作者：
Potluri, R. [1 ]
Farr, A. M. [2 ]
Hirji, I [3 ]
Davis, C. [4 ]
Bhandari, H. [5 ]
Oukessou, A. [4 ]
机构：
[1] SmartAnalyst Inc, New York, NY USA
[2] Truven Hlth Analyt, Bethesda, MD USA
[3] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[4] Bristol Myers Squibb Co, Princeton, NJ USA
[5] SmartAnalyst India Pvt Ltd, Gurgaon, India
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.1134
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN118
引用
收藏
页码：A450 / A450
页数：1
相关论文
共 50 条
  • [1] TREATMENT PATTERNS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS IN GERMANY
    Patel, V
    Kap, E. J.
    Kutikova, L.
    Lebioda, A.
    Schoehl, M.
    Kostev, K.
    VALUE IN HEALTH, 2019, 22 : S923 - S923
  • [2] Real-World Treatment Patterns, Health Care Utilization, and Costs Among Relapsed/Refractory Multiple Myeloma (rrMM) Patients
    Shao, Changxia
    Monberg, Matthew
    Cao, Xiting
    Zhou, Wei
    Zhong, Yichen
    Marinello, Patricia
    BLOOD, 2016, 128 (22)
  • [3] Estimating direct costs of care for patients with relapsed or refractory multiple myeloma in french hospitals
    Armoiry, X.
    Fagnani, F.
    Benboubker, L.
    Facon, T.
    Fermand, J.
    Hulin, C.
    Moreau, P.
    Aulagner, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Treatment Sequencing Patterns Associated with Elderly Patients with Relapsed/Refractory Multiple Myeloma (MM) in the US Community Setting
    Farr, Amanda M.
    Stott-Miller, Marni
    Varker, Helen
    Spencer, Danae
    Shah, Manan
    Chen, Clara
    BLOOD, 2015, 126 (23)
  • [5] Treatment patterns among patients with relapsed/refractory multiple myeloma (RRMM) in Taiwan
    Huang, Jeffrey Shang-Yi
    Wang, Ming-Chung
    Yeh, Su-Peng
    Chen, Tsai-Yun
    Teng, Chieh-Lin Jerry
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S188 - S189
  • [6] Addressing the knowledge gap to optimize treatment sequencing for patients with relapsed/refractory multiple myeloma
    Heller, Elizabeth
    Smith, Keira
    Williams, Sarah
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S171 - S172
  • [7] Carfilzomib for the treatment of patients with relapsed and/or refractory multiple myeloma
    Stewart, A. Keith
    FUTURE ONCOLOGY, 2015, 11 (15) : 2121 - 2136
  • [8] Selinexor for the treatment of patients with relapsed or refractory multiple myeloma
    Babar, Anum
    Babar, Maham
    Zubair, Hina
    Shahid, Arzu
    Rafique, Sana
    Bano, Maimona
    Waleed, Madeeha Subhan
    Khan, Maimoona
    Inayat, Arslan
    Safi, Danish
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (03) : 535 - 546
  • [9] TREATMENT RESPONSE IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA PATIENTS
    Ioana, I.
    Liviu, C.
    Maria, C.
    Claudiu, I.
    Maria, I.
    Mihai, I.
    Dacian, O.
    Ovidiu, P.
    Cristina, S.
    Despina, C.
    Hortensia, I.
    HAEMATOLOGICA, 2013, 98 : 614 - 614
  • [10] Patterns of Medication Use in Patients with Relapsed and/or Refractory Multiple Myeloma
    Hagiwara, May
    Moynahan, Aaron
    Cong, Ze
    Chen, Yaozhu J.
    Duchesneau, Emilie
    Hurley, Dana
    Delea, Thomas E.
    BLOOD, 2015, 126 (23)
12345